NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Seyda Gunduz
Memorial Healthcare Group - İstanbul / Türkiye
Others
AD Scientific Index ID: 4969559
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Seyda Gunduz's MOST POPULAR ARTICLES
1-)
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial T Powles, T Csőszi, M Özgüroğlu, N Matsubara, L Géczi, SYS Cheng, ... The Lancet Oncology 22 (7), 931-945, 2021 1772021
2-)
Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: a multicenter study M Gunaldi, S Goksu, D Erdem, S Gunduz, Y Okuturlar, E Tiken, ... International journal of clinical and experimental medicine 8 (4), 5937, 2015 742015
3-)
LBA23 Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361 A Alva, T Csőszi, M Ozguroglu, N Matsubara, L Geczi, SYS Cheng, ... Annals of Oncology 31, S1155, 2020 732020
4-)
Platelet to lymphocyte ratio as a new prognostic for patients with metastatic renal cell cancerS Gunduz, H Mutlu, D Tural, Ö Yıldız, M Uysal, HS Coskun, H BozcukAsia‐Pacific Journal of Clinical Oncology 11 (4), 288-292, 2015802015
5-)
Prognostic significance of p53 in gastric cancer: a meta-analysisM Yildirim, V Kaya, O Demirpence, S Gunduz, H BozcukAsian Pacific Journal of Cancer Prevention 16 (1), 327-332, 2015602015
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept